Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

The closing of the private placement is expected to occur on or about September 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from ...

Intelligent Bio Solutions shares surge Monday: What's driving the action?

Shares of Intelligent Bio Solutions Inc. INBS are surging Monday afternoon after the medical technology company announced a ...

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

The results form a critical component of the Company's 510 (k) submission package. With all data collection now complete, the Company has accelerated its filing timeline and expects to submit its 510 ...
Nasdaq

Intelligent Bio Solutions Inc. Reports 32.6% Surge in Gross Profit Amid Strategic Growth Initiatives

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...

Intelligent Bio Solutions Advances Fingerprint Drug Test Toward FDA

Intelligent Bio Solutions ( ) has issued an announcement. On September 1, 2026, Intelligent Bio Solutions Inc. reported results from a multi-site Method Comparison Study of its In ...
RTTNews

Intelligent Bio Solutions Secures $5M Funding As Drug Screening System Nears FDA Filing

Intelligent Bio Solutions Inc. ( INBS ), a medical technology company, on Tuesday announced a private placement of approximately $5 million with a single existing institutional investor, while ...
Nasdaq

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...
Yahoo Finance

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, ...
Benzinga.com

EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales

On Thursday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced preliminary fiscal second-quarter sales of approximately $0.61 million and six-month sales of roughly $1.48 million. Gross profit is ...
Benzinga.com

EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%

Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Tuesday reported a third quarter 2025 loss of 44 cents per share, down from a loss of $1.43 a year ago. The noninvasive testing solutions provider ...

Intelligent Bio Solutions Issues Routine Investor Presentation Update

Intelligent Bio Solutions ( ) has provided an announcement. On August 28, 2026, Intelligent Bio Solutions Inc. made an investor presentation available detailing its business and o ...